跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
瑞伐明 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Rivastigmine Hydrogen Tartrate Capsules
Approved
化学药品
Rivastigmine Hydrogen Tartrate Capsules
SUN PHARMACEUTICAL INDUSTRIES LIMITED
🇨🇳 National Medical Products Administration
Approval Date
May 13, 2022
Approval ID
8IE5XMz22Do
Company
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Type
化学药品
Approval Details
Approval Id
8IE5XMz22Do
Approval Number
国药准字HJ20181098
Generic Name
重酒石酸卡巴拉汀胶囊
Generic Name En
Rivastigmine Hydrogen Tartrate Capsules
Brand Name
瑞伐明
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
3mg(以卡巴拉汀计)
Reg Date
2022-05-13
Expired Date
2027-05-12
Company Name
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Production Company Name
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Company Detail Path
/organization/sun-pharmaceutical-industries-limited
Production Company Detail Path
/organization/sun-pharmaceutical-industries-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 13, 2022
Approval ID
8IE5XMz22Do
Type
化学药品
Back to NMPA Approvals